ResMed

Yahoo Finance • 28 days ago

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Health... Full story

Yahoo Finance • last month

Wall Street searches for guidance as investors await Fed's rate decision

[Republican Politics and Wall Street] Douglas Rissing Wall Street's major averages were mixed, swinging on both sides of the flat line on Wednesday as all focus is on the Federal Reserve's final interest rate decision of the year this aft... Full story

Yahoo Finance • last month

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administratio... Full story

Yahoo Finance • last month

Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines?

If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the numbers indicate about its value. ResMe... Full story

Yahoo Finance • last month

Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed

(RTTNews) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments. Sensei Biotherapeutics Inc. (SNSE) soared 62.9% to $17.20... Full story

Yahoo Finance • last month

LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea

LONDON, December 02, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effect... Full story

Yahoo Finance • 2 months ago

Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Company Logo The Sleep Apnea Devices industry is set to grow from US$ 6.47 Billion in 2024 to an impressive US$ 12.23 Billion by 2033, at a CAGR of 7.32% from 2025 to 2033. This surge is driven by increasing sleep disorder rates, notably... Full story

Yahoo Finance • 2 months ago

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fu... Full story

Yahoo Finance • 2 months ago

22% Of This ResMed Insider's Holdings Were Sold

Insiders were net sellers of ResMed Inc.'s (NYSE:RMD ) stock during the past year. That is, insiders sold more stock than they bought. While insider transactions are not the most important thing when it comes to long-term investing, we wo... Full story

Yahoo Finance • 2 months ago

3 Rule Breaker Investing Hacks From David Gardner's Latest Book

Key Points Much of David Gardner's advice bucks traditional investing wisdom. He doesn't recommend following the traditional wisdom to buy low and sell high, and he's open to buying companies that are considered overvalued. He looks for c... Full story

Yahoo Finance • 3 months ago

Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand

Resmed Inc.’s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2026 were $2.55, up 15.9% year over year. The metric beat the Zacks Consensus Estimate by 2.41%. The adjustments include certain non-recurring expenses/ben... Full story

Yahoo Finance • 3 months ago

ResMed Non-GAAP EPS of $2.55 beats by $0.05, revenue of $1.3B misses by $30M

* ResMed press release [https://seekingalpha.com/pr/20287382-resmed-inc-announces-results-for-the-first-quarter-of-fiscal-year-2026] (RMD [https://seekingalpha.com/symbol/RMD]): Q1 Non-GAAP EPS of $2.55 beats by $0.05. * Revenue of $1.... Full story

Yahoo Finance • 3 months ago

Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage

Company Logo The global home healthcare market is projected to reach USD 473.8 billion by 2030, up from USD 309.9 billion in 2025, growing at a CAGR of 8.9%. This expansion is driven by rising lifestyle-related disorders such as high bloo... Full story

Yahoo Finance • 3 months ago

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk and J&J in focus

U.S. stocks wavered amid increased volatility on Friday but managed to resurge, as Wall Street was rattled by concerns on the health of regional banks and credit risks while the U.S. government shutdown entered its 17th day. The benchmark... Full story

Yahoo Finance • 3 months ago

RMD secures precision positioning contract in Sweden

Railway Metrics and Dynamics (RMD) has been awarded a contract to supply a precision positioning service to the Swedish Transport Administration (Trafikverket) for railway vehicles. The framework agreement, which is estimated at an annual... Full story

Yahoo Finance • 3 months ago

2 Cash-Heavy Stocks to Research Further and 1 We Turn Down

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. Just because a business has cash doesn’t... Full story

Yahoo Finance • 3 months ago

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York S... Full story

Yahoo Finance • 3 months ago

YieldBoost Intuit From 0.7% To 3.4% Using Options

Shareholders of Intuit Inc (Symbol: INTU) looking to boost their income beyond the stock's 0.7% annualized dividend yield can sell the January 2028 covered call at the $980 strike and collect the premium based on the $40.00 bid, which annu... Full story

Yahoo Finance • 3 months ago

Saudi Arabia $5.94 Bn Sleep Apnea Devices Market Trends, Competition, Forecast & Opportunities, 2030F Featuring ResMed, Philips, Invacare, Itamar Medical, and Nihon Kohden

Company Logo The Saudi Arabia Sleep Apnea Devices Market offers growth opportunities driven by rising OSA awareness and demand for diagnostic and therapeutic technologies. Key trends include integrating digital health tools and remote mon... Full story

Yahoo Finance • 4 months ago

Anesthesia and Respiratory Devices Global Markets Report 2025-2030, Profiles of Prominent Players - F. Hoffmann-La Roche, Koninklijke Philips, ResMed, Teleflex, GE Healthcare, and Medtronic

Company Logo Key market opportunities in anesthesia and respiratory devices include technological advancements, regulatory developments, and growing demand for patient monitoring, ventilators, and disposable products. Companies can levera... Full story